KALEIDO BIOSCIENCES INC's ticker is KLDO and the CUSIP is 483347100. A total of 46 filers reported holding KALEIDO BIOSCIENCES INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $511,000 | -37.3% | 309,692 | -9.2% | 0.04% | -23.1% |
| Q4 2021 | $815,000 | -81.0% | 341,030 | -56.6% | 0.05% | -79.9% |
| Q3 2021 | $4,294,000 | -26.6% | 786,400 | 0.0% | 0.26% | -19.6% |
| Q2 2021 | $5,851,000 | -8.1% | 786,400 | 0.0% | 0.32% | -11.3% |
| Q1 2021 | $6,370,000 | -11.0% | 786,400 | 0.0% | 0.36% | -3.2% |
| Q4 2020 | $7,156,000 | -17.8% | 786,400 | 0.0% | 0.38% | -21.5% |
| Q3 2020 | $8,705,000 | +49.0% | 786,400 | 0.0% | 0.48% | +36.2% |
| Q2 2020 | $5,843,000 | +20.6% | 786,400 | -0.2% | 0.35% | -13.5% |
| Q1 2020 | $4,846,000 | +22.5% | 787,999 | 0.0% | 0.41% | +86.2% |
| Q4 2019 | $3,956,000 | -33.3% | 787,999 | 0.0% | 0.22% | -44.8% |
| Q3 2019 | $5,934,000 | -41.0% | 787,999 | -9.1% | 0.40% | -19.2% |
| Q2 2019 | $10,053,000 | -20.0% | 866,666 | 0.0% | 0.49% | -6.7% |
| Q1 2019 | $12,567,000 | – | 866,666 | – | 0.52% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 17,360,710 | $106,768,000 | 5.00% |
| HARBOURVEST PARTNERS LLC | 1,167,166 | $7,178,000 | 3.46% |
| Palo Alto Investors LP | 787,999 | $4,846,000 | 0.41% |
| Artal Group S.A. | 500,500 | $3,078,000 | 0.13% |
| BAINCO INTERNATIONAL INVESTORS | 22,037 | $136,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 106,700 | $656,000 | 0.02% |
| Baillie Gifford | 440,000 | $2,706,000 | 0.00% |
| FMR LLC | 2,276,007 | $13,997,000 | 0.00% |
| MANCHESTER FINANCIAL INC | 200 | $1,000 | 0.00% |
| VICTORY CAPITAL MANAGEMENT INC | 250,372 | $1,540,000 | 0.00% |